Nehi (/ ˈ n iː h aɪ / NEE-hy [2]) is a flavored soft drink that originated in the United States. It was introduced in 1924 by Chero-Cola/Union Bottle Works and founded by Claud A. Hatcher, a Columbus, Georgia, grocer who began bottling ginger ale and root beer in 1905. [1]

NEHI is a relatively rare disorder of the lungs that was first classified and described in 2005. As a result, it is difficult to estimate the number of children with this disorder in the US. However, this is one of the most common forms of chILD and is still underdiagnosed.

2023年1月16日 · Yes, Nehi is still being produced and sold today. Nehi is a brand of fruit-flavored, carbonated soft drinks that are made by the Royal Crown Cola company and are known for their refreshing, fruity taste.

Neuroendocrine cell hyperplasia of infancy (NEHI), initially described as persistent tachypnea of infancy, is a rare lung disease first defined in 2005 [1]. The etiology is unknown, but genetic mechanisms may play a role.

Neuroendocrine cell hyperplasia of infancy (NEHI) is a common form of childhood interstitial lung disease. A high‐resolution CT scan is a useful and major imaging approach for assisting in diagnosis. The major characteristics of NEHI on CT are the presence of typical ground glass opacities and air trapping.

Neuroendocrine cell hyperplasia of infancy (NEHI) is a form of children’s interstitial and diffuse lung disease (chILD). It was initially named persistent tachypnea of infancy (1) and subsequently NEHI, after biopsy findings of increased numbers of neuroendocrine cells in …

Children with NEHI often have rapid and difficult breathing, low levels of oxygen in the blood (hypoxemia), and crackles are heard on examination with a stethoscope. Wheezing, although not characteristic, may also occur.

Neuroendocrine cell hyperplasia of infancy (NEHI) is a rare lung disease that was first described and classified in 2005. NEHI is a sub-group of Children’s interstitial lung disease (chILD) that typically presents within the first two years of life.

2024年11月5日 · Neuroendocrine cell hyperplasia of infancy (NEHI) is a rare interstitial lung disease of childhood that typically presents in the first year of life.

Neuroendocrine hyperplasia of infancy (NEHI) is a childhood interstitial lung disease originally reported in the medical literature in 2005. Otherwise healthy former term infants exhibit insidious onset of chronic tachypnea, retractions, and hypoxemia in the first months to years of life (1).